Literature DB >> 34209841

Modulation of Splenic B Cell Subsets during Experimental Leishmania donovani Infection in BALB/c Mice.

Koushik Mondal1,2, Shantanabha Das3, Khudiram Naskar1, Syamal Roy1.   

Abstract

Sodium antimonials are one of the major and common drugs used against visceral form leishmaniasis (VL). However, the development of drug resistance makes it difficult to manage this disease. Current work investigates the modulation of splenic B cells during experimental infection with antimony-sensitive and -resistant Leishmania donovani infection. Here we phenotypically characterized splenic B cell subsets in BALB/c mice infected with antimony drug-sensitive and -resistant VL strains using flow-cytometry method. In the splenocytes we noticed increased number of Transitional T3 B cells and B1a B cells in drug-resistant VL strain infection. Besides, we also observed alteration in Follicular B cell population of antimony-resistant strain infected mice. Drug-resistant strain induced secretion of elevated level of IL-10 from B1a B cells and IL-6 from Transitional T3 B cell subsets in the splenocytes. Purified splenic B cells from antimony drug-resistant strain infected mice showed decrease in the Lyn kinase gene expression compared to sensitive strain infected and uninfected mice. The current study provides insight into changes in host splenic B-cell subsets during experimental infection with antimony-sensitive and -resistant L. donovani in murine model.

Entities:  

Keywords:  B1a B cell; Follicular B cell; Transitional B cell; antimony resistance; cytokines; visceral leishmaniasis

Year:  2021        PMID: 34209841     DOI: 10.3390/pathogens10070814

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  46 in total

1.  B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals.

Authors:  F Loder; B Mutschler; R J Ray; C J Paige; P Sideras; R Torres; M C Lamers; R Carsetti
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

2.  Vaccination with leishmania hemoglobin receptor-encoding DNA protects against visceral leishmaniasis.

Authors:  Rajan Guha; Deepika Gupta; Ruchir Rastogi; Rajagopal Vikram; Ganga Krishnamurthy; Sanjiva Bimal; Syamal Roy; Amitabha Mukhopadhyay
Journal:  Sci Transl Med       Date:  2013-09-11       Impact factor: 17.956

3.  Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1.

Authors:  Budhaditya Mukherjee; Rupkatha Mukhopadhyay; Bijoylaxmi Bannerjee; Sayan Chowdhury; Sandip Mukherjee; Kshudiram Naskar; Uday Sankar Allam; Dipshikha Chakravortty; Shyam Sundar; Jean-Claude Dujardin; Syamal Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

4.  Autoantibody production by patients infected with Leishmania.

Authors:  S Argov; C L Jaffe; M Krupp; H Slor; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

5.  Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation.

Authors:  Eszter Deak; Asha Jayakumar; Ka Wing Cho; Karen Goldsmith-Pestana; Blaise Dondji; John D Lambris; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

6.  Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation.

Authors:  D Allman; R C Lindsley; W DeMuth; K Rudd; S A Shinton; R R Hardy
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

Review 7.  B10 cell regulation of health and disease.

Authors:  Kathleen M Candando; Jacquelyn M Lykken; Thomas F Tedder
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

8.  Defect in the tissue cellular immune response: experimental visceral leishmaniasis in euthymic C57BL/6 ep/ep mice.

Authors:  K E Squires; M Kirsch; S C Silverstein; A Acosta; M J McElrath; H W Murray
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

9.  B-1 cells contribute to susceptibility in experimental infection with Leishmania (Leishmania) chagasi.

Authors:  Wagner Francisco Kennerly Marcondes Gonzaga; Vanessa Xavier; Bruno Camolese Vivanco; José Daniel Lopes; Patricia Xander
Journal:  Parasitology       Date:  2015-10       Impact factor: 3.234

10.  Extracellular Vesicles Released by Leishmania (Leishmania) amazonensis Promote Disease Progression and Induce the Production of Different Cytokines in Macrophages and B-1 Cells.

Authors:  Fernanda Marins Costa Barbosa; Talita Vieira Dupin; Mayte Dos Santos Toledo; Natasha Ferraz Dos Campos Reis; Kleber Ribeiro; André Cronemberger-Andrade; Jeronimo Nunes Rugani; Beatriz Helena Pizarro De Lorenzo; Ronni Rômulo Novaes E Brito; Rodrigo Pedro Soares; Ana Claudia Torrecilhas; Patricia Xander
Journal:  Front Microbiol       Date:  2018-12-21       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.